Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report) shares rose 8.3% during mid-day trading on Friday . The company traded as high as $0.50 and last traded at $0.50. Approximately 1,225 shares changed hands during trading, an increase of 343% from the average daily volume of 277 shares. The stock had previously closed at $0.47.
Mosaic ImmunoEngineering Stock Up 8.3%
The company has a market cap of $3.64 million, a PE ratio of -4.20 and a beta of -1.18. The business’s 50 day moving average price is $0.42 and its 200-day moving average price is $0.63.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last issued its quarterly earnings results on Tuesday, May 20th. The company reported ($0.03) earnings per share (EPS) for the quarter.
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
Featured Stories
- Five stocks we like better than Mosaic ImmunoEngineering
- Best Stocks Under $5.00
- 3 Restaurant Stocks That Will Outperform in Q3 and Q4
- About the Markup Calculator
- The Midstream Energy Play That Keeps Powering Higher
- Investing in Construction Stocks
- Ethereum Near All-Time High: 3 Stocks Stacking ETH in Treasuries
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
